Cannabidiol (CBD) (INN) is one of at least 113 active cannabinoids identified in cannabis. It is a major phytocannabinoid, accounting for up to 40% of the plant’s extract. CBD is considered to have a wide scope of potential medical applications - due to clinical reports showing the lack of side effects, particularly a lack of psychoactivity (as is typically associated with ∆9-THC).
- government licensed operation
- all products are made from legal EU hemp varieties
- a guarantee of natural phytocannabinoid content
EFSA announced on November 27, 2019, that CBDepot's application on trans-Cannabidiol, synthesized as a novel food ingredient has been registered in the Register of Questions with the reference EFSA-Q-2019-00750.